BICD2 and muscular atrophy: Further co‐immunostaining studies are crucial to decipher the nature of extra‐muscular cells presenting with increased NEFM abundance in (VWA1‐ and BICD2‐related) neuromyopathies and neurogenic muscular atrophies.